344 related articles for article (PubMed ID: 22831895)
1. MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kinoshita T; Okamoto Y; Seki N
Auris Nasus Larynx; 2013 Apr; 40(2):143-9. PubMed ID: 22831895
[TBL] [Abstract][Full Text] [Related]
2. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
[TBL] [Abstract][Full Text] [Related]
3. Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Arai T; Okato A; Kikkawa N; Seki N
Cancer Metastasis Rev; 2017 Sep; 36(3):525-545. PubMed ID: 28836104
[TBL] [Abstract][Full Text] [Related]
4. The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):3-13. PubMed ID: 27557665
[TBL] [Abstract][Full Text] [Related]
5. Effect of microRNA-203 on tumor growth in human hypopharyngeal squamous cell carcinoma.
Wang R; Fang J; Ma H; Feng L; Lian M; Yang F; Wang H; Wang Q; Chen X
Mol Cell Biochem; 2015 Jul; 405(1-2):97-104. PubMed ID: 25840888
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
[TBL] [Abstract][Full Text] [Related]
7. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
[TBL] [Abstract][Full Text] [Related]
8. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
[TBL] [Abstract][Full Text] [Related]
9. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
[TBL] [Abstract][Full Text] [Related]
10. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
[TBL] [Abstract][Full Text] [Related]
12. How Long Non-Coding RNAs and MicroRNAs Mediate the Endogenous RNA Network of Head and Neck Squamous Cell Carcinoma: a Comprehensive Analysis.
Zhao G; Fu Y; Su Z; Wu R
Cell Physiol Biochem; 2018; 50(1):332-341. PubMed ID: 30282065
[TBL] [Abstract][Full Text] [Related]
13. MicoRNA-451 is a novel tumor suppressor via targeting c-myc in head and neck squamous cell carcinomas.
Wang H; Zhang G; Wu Z; Lu B; Yuan D; Li X; Lu Z
J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C216-21. PubMed ID: 26506880
[TBL] [Abstract][Full Text] [Related]
14. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma.
Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Fujimura L; Yoshino H; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
Int J Oncol; 2011 Jan; 38(1):209-17. PubMed ID: 21109942
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiles of cancer stem cells in head and neck squamous cell carcinoma.
Yata K; Beder LB; Tamagawa S; Hotomi M; Hirohashi Y; Grenman R; Yamanaka N
Int J Oncol; 2015 Oct; 47(4):1249-56. PubMed ID: 26323893
[TBL] [Abstract][Full Text] [Related]
16. The non-coding landscape of head and neck squamous cell carcinoma.
Zou AE; Zheng H; Saad MA; Rahimy M; Ku J; Kuo SZ; Honda TK; Wang-Rodriguez J; Xuan Y; Korrapati A; Yu V; Singh P; Grandis JR; King CC; Lippman SM; Wang XQ; Hinton A; Ongkeko WM
Oncotarget; 2016 Aug; 7(32):51211-51222. PubMed ID: 27323410
[TBL] [Abstract][Full Text] [Related]
17. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
[TBL] [Abstract][Full Text] [Related]
18. Aberrantly expressed genes and miRNAs in human hypopharyngeal squamous cell carcinoma based on RNA‑sequencing analysis.
Li H; Wang F; Fei Y; Lei Y; Lu F; Guo P; Li W; Xun X
Oncol Rep; 2018 Aug; 40(2):647-658. PubMed ID: 29916534
[TBL] [Abstract][Full Text] [Related]
19. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profile in site-specific head and neck squamous cell cancer.
Kalfert D; Pesta M; Kulda V; Topolcan O; Ryska A; Celakovsky P; Laco J; Ludvikova M
Anticancer Res; 2015 Apr; 35(4):2455-63. PubMed ID: 25862914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
